Evolution of the Average Target: Eurofins Scientific SE

Evolution of the Target Price: Eurofins Scientific SE

Changes in Analyst Recommendations: Eurofins Scientific SE

4195f8675be.CoyadXN2cdhkFAgJKxK_SIML2b8DF8hx6TKaJEkHaRA.Mu_2HhI4J7kRREFCHD_IZdd8m8ZkVKopkFDSXB5PX0Je-O86Hy4fiTF5PA~b8aa136be6b71461e48e7964683f74e1
04-20 AlphaValue/Baader Europe Adjusts Model for Eurofins Scientific Over Reclassified Earnings; EPS Forecasts Down MT
04-18 Eurofins Scientific: Rolling over our model with reclassified EPS figures Alphavalue
04-15 Oddo BHF weighs in on Eurofins Scientific unit disposal Zonebourse
02-17 CIC Corporate Upgrades Eurofins Scientific to Buy Rating, Boosts PT MT
01-29 Eurofins Scientific: Inline results and 2026 outlook; recent re-rating supports our cautious view Alphavalue
01-14 CIC Market Solutions Downgrades Eurofins Scientific to Neutral MT
01-05 Eurofins Scientific, Top Gainer on the CAC 40 at the Close of Monday, January 5, 2026 Zonebourse
01-05 BNP Paribas Upgrades Eurofins Scientific to Outperform Rating, Boosts PT MT
01-05 Eurofins Scientific, Top Gainer on the CAC 40 at Midday Monday, January 5, 2026 Zonebourse
01-05 Eurofins Soars, Boosted by Upbeat Exane Rating Zonebourse
23/10/25 AlphaValue/Baader Europe Cuts Eurofins Scientific Rating, Price Target MT
23/10/25 Berenberg Maintains Eurofins Scientific at Hold Amid Continued BioPharma Segment Headwinds MT
22/10/25 Eurofins Scientific: AlphaValue downgrades stock and lowers target price Zonebourse
22/10/25 AlphaValue/Baader Europe Downgrades Eurofins Scientific to Add, Cuts PT MT
22/10/25 Eurofins Scientific: Resetting valuation and target price following transfer of coverage Alphavalue
21/10/25 Eurofins Scientific: Q3 sales broadly in line, 2025 and 2027 targets reiterated Alphavalue
25/04/25 HSBC Downgrades Eurofins Scientific to Hold, Cuts PT MT
23/04/25 Eurofins Scientific: Reiterated outlook impresses investors Alphavalue
01/04/25 Eurofins: Jefferies still a seller, but raises TP Zonebourse
03/02/25 Bernstein Upgrades Eurofins Scientific to Outperform, Boosts PT MT
31/01/25 Eurofins Scientific: A decent end to FY24: investors jittery with biopharma headwinds Alphavalue
31/01/25 AlphaValue/Baader Europe Keeps Positive Stance on Eurofins Scientific Despite Biopharma Concerns MT
30/01/25 Eurofins Scientific: Investors are unimpressed despite a decent end to FY24 Alphavalue
24/01/25 Eurofins: Barclays downgrades to 'online weighted'. Zonebourse
15/01/25 Eurofins Scientific: Berenberg downgrades to 'hold Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+3.59%
+31.82%
+30.7%
+11.22%
+31.82%
+26.81%
-2.88%
+32.16%
Average +20.65%
Weighted average by Cap. +23.59%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
62.64EUR
Average target price
71.85EUR
Spread / Average Target
+14.70%
High Price Target
93.00EUR
Spread / Highest target
+48.47%
Low Price Target
48.00EUR
Spread / Lowest Target
-23.37%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Kulwinder Rajpal
CIC Corporate & Institutional Banking
CIC Market Solutions
BNP Paribas
AlphaValue/Baader Europe
HSBC
Bernstein
Berenberg Bank
Deutsche Bank Securities
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
62.64EUR
Average target price
71.85EUR
Spread / Average Target
+14.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ERF Stock
  4. Consensus Eurofins Scientific SE